Experts Discuss Safety, Cost-Effectiveness, Patient Outcomes for RTA IV Push Products

Are you up to date on the landscape of considerations regarding ready-to-administer (RTA) IV push products, compared with traditional IV vial products? On Monday, Dec. 1, join our expert faculty, John B. Hertig and Satya Krishna Ramachandran as they examine the holistic costs of waste, taking into account cost-effectiveness data in the selection and implementation of RTA IV push products. They’ll describe new evidence on perioperative opioid use and associated adverse clinical outcomes and share strategies for reducing product waste, organizational costs, and postoperative adverse events.

The Midday Symposium, Ready-to-Administer IV Push Products: A Multidisciplinary Approach to Safety, Cost-Effectiveness, and Patient Outcomes in Health System and Perioperative Settings, takes place from 11:30 a.m. to 1 p.m. PT in room 155, 100 Level, Anaheim Convention Center North. Earn 1.5 hours of CE credit.

The Midday Symposium will also be broadcast as a live webinar for CE credit. If you have colleagues at home who are interested in this topic, encourage them to register for the webinar.

This activity is provided by ASHP and supported by an educational grant from Fresenius Kabi USA, LLC.